| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antibodies for angiogenesis inhibition, vascular targeting and endothelial cell transcytosis
|
Trachsel, Eveline
|
|
2006
|
110-111 |
5-6 |
p. 735-754
20 p.
|
artikel
|
| 2 |
Antibody production
|
Birch, John R.
|
|
2006
|
110-111 |
5-6 |
p. 671-685
15 p.
|
artikel
|
| 3 |
Application and potential limitations of animal models utilized in the development of trastuzumab (Herceptin®): A case study
|
Pegram, Mark
|
|
2006
|
110-111 |
5-6 |
p. 723-734
12 p.
|
artikel
|
| 4 |
Current and future issues in the manufacturing and development of monoclonal antibodies
|
Kozlowski, Steven
|
|
2006
|
110-111 |
5-6 |
p. 707-722
16 p.
|
artikel
|
| 5 |
Editorial Board
|
|
|
2006
|
110-111 |
5-6 |
p. ii-
1 p.
|
artikel
|
| 6 |
Engineered antibody therapeutics
|
Mather, Jennie P.
|
|
2006
|
110-111 |
5-6 |
p. 631-632
2 p.
|
artikel
|
| 7 |
Engineering of therapeutic antibodies to minimize immunogenicity and optimize function
|
Presta, Leonard G.
|
|
2006
|
110-111 |
5-6 |
p. 640-656
17 p.
|
artikel
|
| 8 |
Formulation and delivery issues for monoclonal antibody therapeutics
|
Daugherty, Ann L.
|
|
2006
|
110-111 |
5-6 |
p. 686-706
21 p.
|
artikel
|
| 9 |
Latest technologies for the enhancement of antibody affinity
|
Wark, Kim L.
|
|
2006
|
110-111 |
5-6 |
p. 657-670
14 p.
|
artikel
|
| 10 |
Natural IgM antibodies: The orphaned molecules in immune surveillance
|
Vollmers, H. Peter
|
|
2006
|
110-111 |
5-6 |
p. 755-765
11 p.
|
artikel
|
| 11 |
Therapeutic antibodies — Delivering the promise?
|
Hale, Geoff
|
|
2006
|
110-111 |
5-6 |
p. 633-639
7 p.
|
artikel
|
Tijdschrift beschrijving